Cincinnati-based Meridian Bioscience Inc. completed its planned acquisition of GenePOC Inc., a Quebec-based manufacturer of molecular diagnostic instruments and assays.

The company entered into a deal of up to $120 million with GenePOC in late April, with $50 million cash payable at closing and additional future payments of up to $70 million on achieving certain milestones.

Meridian was targeting to complete the transaction by early fourth quarter of 2019.